PubRank

W G Robey

Author PubWeight™ 79.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 1986 6.33
2 Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A 1986 5.55
3 Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 1985 5.42
4 Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A 1986 4.68
5 Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses 1987 3.67
6 Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. Science 1986 2.35
7 Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol 1987 2.28
8 Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A 1987 2.25
9 Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol 1988 1.95
10 In vitro generation of an HTLV-III variant by neutralizing antibody. J Immunol 1986 1.91
11 HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 1987 1.69
12 HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol 1988 1.63
13 Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. J Virol 1989 1.61
14 Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell 1977 1.56
15 Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 1987 1.49
16 Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proc Natl Acad Sci U S A 1987 1.46
17 Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A 1986 1.43
18 Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines. J Gen Virol 1976 1.38
19 Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Proc Natl Acad Sci U S A 1987 1.37
20 A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A 1975 1.37
21 Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res Hum Retroviruses 1993 1.32
22 Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses 1987 1.26
23 Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J Virol 1985 1.26
24 Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1987 1.14
25 Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol 1987 1.05
26 A specific assay measuring binding of 125I-Gp 120 from HIV to T4+/CD4+ cells. J Immunol Methods 1987 1.05
27 Phosphorylation and nucleic acid binding properties of m1 Moloney murine sarcoma virus-specific pP60gag. J Virol 1977 1.05
28 Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Cancer Res 1985 1.01
29 HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia. J Immunol 1987 1.01
30 Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J Gen Virol 1988 0.98
31 Characterization of virus-specified proteins present in NRK cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Cold Spring Harb Symp Quant Biol 1980 0.97
32 Thermolabile protein kinase molecules in a temperature-sensitive murine sarcoma virus pseudotype. Proc Natl Acad Sci U S A 1979 0.96
33 Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF. J Virol 1988 0.93
34 Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine 1989 0.90
35 Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures. Virology 1985 0.90
36 Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines. Cancer Res 1982 0.89
37 Activation of a C-type virus from the human carcinoma cell line HBT-3 by iododeoxyuridine and testosterone. Nature 1974 0.89
38 Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic mice. Cancer Res 1987 0.87
39 Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins. J Virol Methods 1988 0.85
40 HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus. Lancet 1986 0.83
41 Purification of herpesvirus saimiri and properties of the viral DNA. Arch Virol 1975 0.81
42 Restricted heterogeneity of antibody to gp120 and p24 in AIDS. J Immunol 1988 0.80
43 Biological, immunological, and molecular properties of revertants of cat cells transformed by murine sarcoma virus. Cancer Res 1981 0.78
44 Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein. Haematol Blood Transfus 1987 0.78
45 Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells. Cancer Res 1982 0.78
46 Stages in the progression of HIV infection in chimpanzees. AIDS Res Hum Retroviruses 1987 0.77
47 Molecular biological characterization of a highly leukaemogenic virus isolated from the mouse. IV. Viral proteins. J Gen Virol 1984 0.77
48 Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies. AIDS Res Hum Retroviruses 1988 0.76
49 Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus. Int J Radiat Oncol Biol Phys 1985 0.76
50 Lysine tRNA's associated with avian myeloblastosis virus 70S RNA. J Virol 1976 0.75
51 Generation of recombinant murine leukemia viruses de novo: an alternative model for leukemogenesis. Haematol Blood Transfus 1983 0.75
52 Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus. Virology 1985 0.75
53 Determination of anti-HBsAg IgM monoclonal antibodies in cell culture media by perfusion immunoassay. J Immunol Methods 1997 0.75
54 A cell-free mammalian protein-synthesizing system stimulated by RNA from avian myeloblastosis virus. Biochim Biophys Acta 1975 0.75
55 The role of viral and cellular recombinational events in murine leukemia. Transplant Proc 1984 0.75
56 Persistence of one species of oncovirus in mixed infection after antiserum treatment or transspecies rescue. J Gen Virol 1982 0.75
57 Properties of Moloney sarcoma virus-specific p60 and its detection in transformed cells. Bibl Haematol 1975 0.75
58 Comparative peptide mapping of a hepatitis C viral recombinant protein by capillary electrophoresis and matrix-assisted laser desorption time-of-flight mass spectrometry. J Chromatogr A 1996 0.75
59 Purification of commercial coomassie brilliant blue R-250 and characterization of the chromogenic fractions. Anal Biochem 1996 0.75
60 Purity testing of recombinant proteins by capillary electrophoresis. J Capillary Electrophor 1997 0.75